ProfileJobs

Mesa Laboratories

Healthmeasuringmedical devicesmonitoringpharma

Mesa Laboratories, Inc., develops, manufactures and markets high-quality process validation, monitoring and calibration instruments and consumables worldwide. Its products are used to assure product quality, control manufacturing processes, and to solve problems in niche markets in healthcare, industrial, pharmaceutical, medical and food processing applications.
Mesa offers high-quality data loggers for monitoring temperature, humidity, and pressure and biological indicators (BIs) for medical device and pharmaceutical manufacturing sterilization monitoring. The Company also offers cap torque testers which are durable, reliable and computerized cap torque analyzers, which is setting a new standard for torque measurement throughout the packaging industry. 

Revenue(FY, 2017)
$93.7 M
Market capitalization(2017-08-22)
$512.8 M
Company Growth (employees)
Type
Public
HQ
Lakewood, US
Founded
1982
Size (employees)
381 (est)+4%
Website
mesalabs.com
Mesa Laboratories was founded in 1982 and is headquartered in Lakewood, US

Mesa Laboratories Office Locations

Mesa Laboratories has offices in Lakewood, Omaha, Bozeman, Butler and in 3 other locations
Lakewood, US (HQ)
12100 W 6th Ave Frontage Rd
Traverse City, US
13606 S W Bay Shore Dr
Markham, CA
3075 14th Ave
Chassieu, FR
2 Rue Augustin Fresnel
Butler, US
10 Park Pl
Bozeman, US
10 Evergreen Dr
Show all (7)

Mesa Laboratories Data and Metrics

Mesa Laboratories Financial Metrics

Mesa Laboratories's revenue was reported to be $93.7 m in FY, 2017 which is a 11% increase from the previous period.
USD

Revenue (FY, 2017)

93.7 m

Revenue growth (FY, 2016 - FY, 2017), %

11%

Gross profit (FY, 2017)

79.8 m

Gross profit margin (FY, 2017), %

85%

Net income (FY, 2017)

11.2 m

EBIT (FY, 2017)

16.3 m

Market capitalization (22-Aug-2017)

512.8 m

Cash (31-Mar-2017)

5.8 m

EV

508.1 m
Mesa Laboratories's current market capitalization is $512.8 m.
USDFY, 2015FY, 2016FY, 2017

Revenue

71.3 m84.7 m93.7 m

Revenue growth, %

35%19%11%

Cost of goods sold

6.3 m13.9 m

Gross profit

78.4 m79.8 m

Gross profit Margin, %

93%85%

R&D expense

4.2 m

General and administrative expense

22.8 m

Operating expense total

27 m

EBIT

15.9 m16.3 m16.3 m

EBIT margin, %

22%19%17%

Pre tax profit

14.3 m

Income tax expense

4.4 m3.1 m

Net Income

9.6 m11.2 m11.2 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Revenue

16.4 m18.5 m17.8 m18.2 m21.8 m19.9 m21.1 b24.4 b23.8 b

Cost of goods sold

6.7 m7.4 m6.8 m7 m8.7 m7.7 m9.1 b10.7 b10.3 b

Gross profit

9.7 m11.1 m11.1 m11.1 m13.1 m12.2 m12 b13.7 b13.5 b

Gross profit Margin, %

59%60%62%61%60%61%57%56%57%

R&D expense

751 k876 k832 k963 k991 k975 k1 b1 b861 m

General and administrative expense

3.8 m4 m4.7 m4.7 m6.8 m5.9 m6 b6 b5.9 b

Operating expense total

4.6 m4.9 m5.6 m5.7 m7.8 m6.9 m7 b7 b6.7 b

EBIT

3.1 m4.9 m3.7 m3.6 m3 m3.8 m2.6 b4 b4.4 b

EBIT margin, %

19%26%21%20%14%19%12%16%18%

Pre tax profit

2.9 m4.7 m3.7 m3.5 m2.8 m3.5 m2.2 b3.2 b3.9 b

Income tax expense

1 m1.7 m1.3 m1.2 m1 m1.1 m239 m854 m628 m

Net Income

1.9 m3.1 m2.4 m2.3 m1.8 m2.4 m1.9 b2.4 b3.3 b
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

5.6 m2 m5.7 m5.8 m

Accounts Receivable

9.3 m12.1 m

Inventories

13.9 m

Current Assets

26.6 m29.6 m37.2 m35.8 m

PP&E

7.7 m9.6 m16.6 m26 m

Goodwill

37.9 m44.9 m66.1 m72.2 m

Total Assets

97.5 m117.3 m160.7 m171.7 m

Accounts Payable

2 m2.5 m2.8 m2.2 m

Total Debt

26.3 m45.3 m1.1 m

Current Liabilities

10.2 m14.7 m24 m16.6 m

Total Liabilities

73.9 m

Retained Earnings

48.6 m56 m64.8 m73.7 m

Total Equity

84.7 m97.8 m

Debt to Equity Ratio

0.5 x0 x

Debt to Assets Ratio

0.2 x0.3 x0 x

Financial Leverage

1.9 x1.8 x
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Cash

3.2 m3.7 m1.4 m2 m5.5 m3.3 m4.6 m5.1 m5.4 m

Accounts Receivable

10.8 m11.8 m11.8 m11.2 m12.7 m13.3 m

Inventories

10 m10.6 m12.6 m12.9 m13.4 m14.7 m14.1 m14.4 m14.6 m

Current Assets

28.1 m30.8 m29.3 m29.3 m35 m34.2 m32.5 m34.3 m35 m

PP&E

7.9 m8.2 m9.2 m11 m14.7 m15.7 m19.5 m22.1 m24.3 m

Goodwill

42.3 m42.3 m44.1 m44.9 m65.4 m64 m69.2 m70.4 m71.9 m

Total Assets

110.3 m112.1 m116.2 m117.2 m155.9 m155.1 m162.1 m166.3 m170.5 m

Accounts Payable

2.1 m2.7 m2.8 m2.3 m3 m3.1 m2.8 m3.5 m2.9 m

Current Liabilities

12.4 m13.3 m12.7 m13 m23.9 m20.9 m22.5 m21.8 m22 m

Retained Earnings

49.9 m52.5 m54.3 m57.7 m58.9 m60.7 m66.2 m67.9 m70.6 m

Total Equity

76.4 m78.9 m80.6 m87.7 m90.3 m93.7 m

Financial Leverage

1.5 x2 x1.9 x1.8 x1.8 x1.8 x
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

9 m9.6 m11.2 m11.2 m

Depreciation and Amortization

3.8 m5.7 m7.2 m8.7 m

Accounts Receivable

697 k(2.3 m)(2 m)994 k

Accounts Payable

754 k410 k(150 k)(655 k)

Cash From Operating Activities

12.4 m10.8 m16.9 m7.8 m

Purchases of PP&E

(22.8 m)(20.5 m)(24.1 m)(6.8 m)

Cash From Investing Activities

(23.1 m)(23.4 m)(31.8 m)(18.4 m)

Cash From Financing Activities

12.3 m9.1 m18.6 m10.7 m

Interest Paid

133 k499 k848 k1.4 m

Income Taxes Paid

4.7 m3.3 m4 m5.6 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Net Income

1.9 m3.1 m2.4 m2.3 m1.8 m2.4 m1.9 b2.4 b3.3 b

Accounts Receivable

10.8 m11.8 m11.8 m11.2 m12.7 m13.3 m

Accounts Payable

2.1 m2.7 m2.8 m2.3 m3 m3.1 m2.8 m3.5 m2.9 m
USDY, 2017

EV/EBIT

31.1 x

EV/CFO

65.6 x

Revenue/Employee

250.4 k

Financial Leverage

1.8 x

Mesa Laboratories Operating Metrics

FY, 2015FY, 2016FY, 2017

Distributors

285266260

    Mesa Laboratories Market Value History

    Mesa Laboratories Revenue Breakdown

    Market Position of Mesa Laboratories

    Competitors

    Transonic Combustion
    Health - Private
    Gerresheimer
    Health - Public
    Avedro
    Health - Private
    OptiNose
    Health - Private
    Compare competitors

    Traffic Overview of Mesa Laboratories

    Mesa Laboratories Online and Social Media Presence

    Mesa Laboratories News and Updates

    August 10, 2016

    BRIEF-Mesa Laboratories - Acquisition of certain assets and liabilities of Rapid Aid Corp by Unit

    * Mesa Laboratories Inc says acquisition of certain assets and liabilities of Rapid Aid Corp by co's subsidiary, Mesa Canada, Inc

    Mesa Laboratories Company Life and Culture

    You may also be interested in